Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bukowski

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Journal of Biological Response Modifiers|December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effectsR M Bukowski, S Murthy, J Sergi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trialR L Miller, R M Bukowski, G T Budd, et al.
Journal of the National Cancer Institute|April 28, 1999
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinomaR G Uzzo, P E Clark, P Rayman, et al.
Cancer|February 15, 1992
A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinomaR M Bukowski, G Inoshita, P Yalavarthi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of WR-2721 and carboplatinG T Budd, R Ganapathi, L Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinomaR A Figlin, J A Thompson, R M Bukowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerL R Laufman, R M Bukowski, M A Collier, et al.
Cancer|September 26, 1997
Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumorsG T Budd, R Ganapathi, D J Adelstein, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignanciesR M Bukowski, J S Sergi, G T Budd, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effectsR M Bukowski, S A Murthy, J Finke, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Journal of Biological Response Modifiers|December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effectsR M Bukowski, S Murthy, J Sergi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trialR L Miller, R M Bukowski, G T Budd, et al.
Journal of the National Cancer Institute|April 28, 1999
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinomaR G Uzzo, P E Clark, P Rayman, et al.
Cancer|February 15, 1992
A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinomaR M Bukowski, G Inoshita, P Yalavarthi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of WR-2721 and carboplatinG T Budd, R Ganapathi, L Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinomaR A Figlin, J A Thompson, R M Bukowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerL R Laufman, R M Bukowski, M A Collier, et al.
Cancer|September 26, 1997
Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumorsG T Budd, R Ganapathi, D J Adelstein, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignanciesR M Bukowski, J S Sergi, G T Budd, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effectsR M Bukowski, S A Murthy, J Finke, et al.
Pageof 17